MCID: CHN039
MIFTS: 40

Chondrodysplasia Punctata, X-Linked Dominant malady

Categories: Genetic diseases, Rare diseases, Eye diseases, Bone diseases, Skin diseases, Metabolic diseases, Fetal diseases

Aliases & Classifications for Chondrodysplasia Punctata, X-Linked Dominant

About this section
Sources:
12diseasecard, 26GTR, 30ICD10 via Orphanet, 36MedGen, 38MeSH, 47NIH Rare Diseases, 49Novoseek, 51OMIM, 53Orphanet, 63The Human Phenotype Ontology, 67UMLS, 68UMLS via Orphanet, 69UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Chondrodysplasia Punctata, X-Linked Dominant:

Name: Chondrodysplasia Punctata, X-Linked Dominant 51 47 12
Cdpx2 47 53 69 49
Chondrodysplasia Punctata 2, X-Linked Dominant 51 69
Chondrodysplasia Punctata 2 X-Linked Dominant 47 26
Happle Syndrome 47 69
Cdpxd 47 53
Cpxd 47 53
Chondrodysplasia Punctata, X-Linked Dominant Type 67
X-Linked Dominant Chondrodysplasia Punctata 53
X-Linked Chondrodysplasia Punctata Type 2 53
 
Chondrodystrophia Calcificans Congenita 53
Conradi-Hünermann-Happle Syndrome 53
Conradi-Hunermann-Happle Syndrome 69
Conrad Hunermann Happle Syndrome 47
Conradi-Hunermann Syndrome 69
Conradi Hunermann Syndrome 47
Chondrodysplasia Punctata 67
Cartilage-Hair Hypoplasia 67
Chh 69

Characteristics:

Orphanet epidemiological data:

53
cdpx2:
Inheritance: X-linked dominant; Prevalence: 1-9/1000000 (Europe); Age of onset: Infancy,Neonatal; Age of death: normal life expectancy

HPO:

63
chondrodysplasia punctata, x-linked dominant:
Inheritance: x-linked dominant inheritance
Onset and clinical course: congenital onset, variable expressivity

Classifications:



External Ids:

OMIM51 302960
Orphanet53 ORPHA35173
UMLS via Orphanet68 C0263627, C0282102
ICD10 via Orphanet30 Q77.3
MeSH38 D002806

Summaries for Chondrodysplasia Punctata, X-Linked Dominant

About this section
OMIM:51 Chondrodysplasia punctata (CDP) is a clinically and genetically heterogeneous disorder characterized by punctiform... (302960) more...

MalaCards based summary: Chondrodysplasia Punctata, X-Linked Dominant, also known as cdpx2, is related to cartilage-hair hypoplasia and smith-lemli-opitz syndrome, and has symptoms including epicanthus, ptosis and abnormality of the fingernails. An important gene associated with Chondrodysplasia Punctata, X-Linked Dominant is EBP (Emopamil Binding Protein (Sterol Isomerase)), and among its related pathways are cholesterol biosynthesis I and Terpenoid backbone biosynthesis. Affiliated tissues include bone, skin and eye.

NIH Rare Diseases:47 X-linked dominant chondrodysplasia punctata (CDPX2), also known as Conradi-Hünermann-Happle syndrome, is a rare form of skeletal dysplasia characterized by skeletal malformations, skin abnormalities, cataracts and short stature. The specific symptoms and severity of the disorder may vary greatly from one individual to another. CDPX2 is caused by mutations in the emopamil binding protein gene, EBP. In many cases, this mutation occurs randomly, for no apparent reason (i.e., new mutation). The condition  is inherited as an X-linked dominant trait and occurs almost exclusively in females.Treatment of CDPX2 is directed toward the specific symptoms that present in each individual. Such treatment may require the coordinated efforts of a team of medical professionals, including physicians who diagnose and treat disorders of the skeleton, joints, muscles, and related tissues (orthopedists); skin specialists (dermatologists); eye specialists; and/or other health care professionals. Last updated: 11/18/2011

UniProtKB/Swiss-Prot:69 Chondrodysplasia punctata 2, X-linked dominant: A clinically and genetically heterogeneous disorder characterized by punctiform calcification of the bones. The key clinical features of CDPX2 are chondrodysplasia punctata, linear ichthyosis, cataracts and short stature. CDPX2 is a rare disorder of defective cholesterol biosynthesis, biochemically characterized by an increased amount of 8- dehydrocholesterol and cholest-8(9)-en-3-beta-ol in the plasma and tissues.

Related Diseases for Chondrodysplasia Punctata, X-Linked Dominant

About this section

Graphical network of diseases related to Chondrodysplasia Punctata, X-Linked Dominant:



Diseases related to chondrodysplasia punctata, x-linked dominant

Symptoms for Chondrodysplasia Punctata, X-Linked Dominant

About this section

Symptoms by clinical synopsis from OMIM:

302960

Clinical features from OMIM:

302960

Human phenotypes related to Chondrodysplasia Punctata, X-Linked Dominant:

 63 53 (show all 71)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 epicanthus63 53 hallmark (90%) Very frequent (99-80%) HP:0000286
2 ptosis63 53 hallmark (90%) Very frequent (99-80%) HP:0000508
3 abnormality of the fingernails63 53 hallmark (90%) Very frequent (99-80%) HP:0001231
4 abnormal joint morphology63 hallmark (90%) HP:0001367
5 kyphosis63 53 hallmark (90%) Very frequent (99-80%) HP:0002808
6 short stature63 53 hallmark (90%) Very frequent (99-80%) HP:0004322
7 ichthyosis63 hallmark (90%) HP:0008064
8 abnormal hair quantity63 hallmark (90%) HP:0011362
9 asymmetric growth63 hallmark (90%) HP:0100555
10 optic atrophy63 53 typical (50%) Frequent (79-30%) HP:0000648
11 abnormality of the teeth63 53 occasional (7.5%) Occasional (29-5%) HP:0000164
12 malar flattening63 53 occasional (7.5%) Occasional (29-5%) HP:0000272
13 sensorineural hearing impairment63 53 occasional (7.5%) Occasional (29-5%) HP:0000407
14 microcornea63 53 occasional (7.5%) Occasional (29-5%) HP:0000482
15 cataract63 53 occasional (7.5%) Occasional (29-5%) HP:0000518
16 foot polydactyly63 53 occasional (7.5%) Occasional (29-5%) HP:0001829
17 talipes63 occasional (7.5%) HP:0001883
18 frontal bossing63 53 occasional (7.5%) Occasional (29-5%) HP:0002007
19 abnormality of the hip bone63 occasional (7.5%) HP:0003272
20 abnormal form of the vertebral bodies63 occasional (7.5%) HP:0003312
21 clinodactyly of the 5th finger63 53 occasional (7.5%) Occasional (29-5%) HP:0004209
22 aplasia/hypoplasia affecting the eye63 occasional (7.5%) HP:0008056
23 aplasia/hypoplasia of the skin63 53 occasional (7.5%) Occasional (29-5%) HP:0008065
24 limb undergrowth63 occasional (7.5%) HP:0009826
25 hypoplasia of the zygomatic bone63 occasional (7.5%) HP:0010669
26 abnormality of hair texture63 53 occasional (7.5%) Occasional (29-5%) HP:0010719
27 postaxial polydactyly63 rare (5%) HP:0100259
28 hydronephrosis63 HP:0000126
29 hearing impairment63 HP:0000365
30 abnormality of the pinna63 HP:0000377
31 short neck63 HP:0000470
32 downslanted palpebral fissures63 HP:0000494
33 glaucoma63 HP:0000501
34 sparse and thin eyebrow63 HP:0000535
35 microphthalmia63 53 Occasional (29-5%) HP:0000568
36 nystagmus63 HP:0000639
37 sparse eyelashes63 HP:0000653
38 abnormality of the thorax63 HP:0000765
39 edema63 HP:0000969
40 erythroderma63 HP:0001019
41 dandy-walker malformation63 HP:0001305
42 failure to thrive63 HP:0001508
43 polyhydramnios63 HP:0001561
44 alopecia63 HP:0001596
45 bilateral talipes equinovarus63 HP:0001776
46 intellectual disability, moderate63 HP:0002342
47 abnormality of pelvic girdle bone morphology63 HP:0002644
48 scoliosis63 HP:0002650
49 tracheal stenosis63 HP:0002777
50 tracheal calcification63 HP:0002787
51 hemivertebrae63 HP:0002937
52 patellar dislocation63 HP:0002999
53 elevated 8-dehydrocholesterol63 HP:0003462
54 elevated 8(9)-cholestenol63 HP:0003465
55 stippled calcification in carpal bones63 HP:0004241
56 congenital ichthyosiform erythroderma63 53 Very frequent (99-80%) HP:0007431
57 tarsal stippling63 HP:0008131
58 punctate vertebral calcifications63 HP:0008420
59 postnatal growth retardation63 HP:0008897
60 epiphyseal stippling63 HP:0010655
61 concave nasal ridge63 HP:0011120
62 flat face63 53 Occasional (29-5%) HP:0012368
63 hemiatrophy63 53 Very frequent (99-80%) HP:0100556
64 joint dislocation53 Very frequent (99-80%)
65 hip dysplasia53 Occasional (29-5%)
66 talipes equinovarus53 Occasional (29-5%)
67 abnormality of the vertebrae53 Occasional (29-5%)
68 scarring alopecia of scalp53 Very frequent (99-80%)
69 abnormality of epiphysis morphology53 Occasional (29-5%)
70 rhizomelia53 Occasional (29-5%)
71 erythema53 Very frequent (99-80%)

Drugs & Therapeutics for Chondrodysplasia Punctata, X-Linked Dominant

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Chondrodysplasia Punctata, X-Linked Dominant

Genetic Tests for Chondrodysplasia Punctata, X-Linked Dominant

About this section

Genetic tests related to Chondrodysplasia Punctata, X-Linked Dominant:

id Genetic test Affiliating Genes
1 Chondrodysplasia Punctata 2 X-Linked Dominant26

Anatomical Context for Chondrodysplasia Punctata, X-Linked Dominant

About this section

MalaCards organs/tissues related to Chondrodysplasia Punctata, X-Linked Dominant:

35
Bone, Skin, Eye

Animal Models for Chondrodysplasia Punctata, X-Linked Dominant or affiliated genes

About this section

Publications for Chondrodysplasia Punctata, X-Linked Dominant

About this section

Articles related to Chondrodysplasia Punctata, X-Linked Dominant:

idTitleAuthorsYear
1
Clinical variation in X-linked dominant chondrodysplasia punctata (X-linked dominant ichthyosis). (16536827)
2006

Variations for Chondrodysplasia Punctata, X-Linked Dominant

About this section

UniProtKB/Swiss-Prot genetic disease variations for Chondrodysplasia Punctata, X-Linked Dominant:

69
id Symbol AA change Variation ID SNP ID
1EBPp.Glu80LysVAR_012105rs28936073
2EBPp.Arg110GlnVAR_012106
3EBPp.Arg147GlyVAR_012107
4EBPp.Arg147HisVAR_012108rs28935174
5EBPp.Glu103LysVAR_074637

Clinvar genetic disease variations for Chondrodysplasia Punctata, X-Linked Dominant:

5 (show all 38)
id Gene Variation Type Significance SNP ID Assembly Location
1EBPNM_006579.2(EBP): c.87G> A (p.Trp29Ter)SNVPathogenicrs104894798GRCh37Chr X, 48382246: 48382246
2EBPNM_006579.2(EBP): c.187C> T (p.Arg63Ter)SNVPathogenicrs104894799GRCh37Chr X, 48382346: 48382346
3EBPNM_006579.2(EBP): c.238G> A (p.Glu80Lys)SNVPathogenicrs104894800GRCh37Chr X, 48382397: 48382397
4EBPEBP, IVS3DS, G-T, +1SNVPathogenicChr na, -1: -1
5EBPEBP, 1-BP DEL, 390AdeletionPathogenicChr na, -1: -1
6EBPEBP, 1-BP INS, 586AinsertionPathogenicChr na, -1: -1
7EBPNM_006579.2(EBP): c.386G> A (p.Trp129Ter)SNVPathogenicrs104894792GRCh37Chr X, 48385590: 48385590
8EBPNM_006579.2(EBP): c.523C> T (p.Gln175Ter)SNVPathogenicrs104894793GRCh37Chr X, 48386675: 48386675
9EBPNM_006579.2(EBP): c.587G> A (p.Trp196Ter)SNVPathogenicrs104894794GRCh37Chr X, 48386739: 48386739
10EBPNM_006579.2(EBP): c.440G> A (p.Arg147His)SNVPathogenicrs28935174GRCh37Chr X, 48385644: 48385644
11EBPNM_006579.2(EBP): c.141G> T (p.Trp47Cys)SNVPathogenicrs587783599GRCh37Chr X, 48382300: 48382300
12EBPNM_006579.2(EBP): c.182G> A (p.Trp61Ter)SNVPathogenicrs587783600GRCh37Chr X, 48382341: 48382341
13EBPNM_006579.2(EBP): c.204G> T (p.Trp68Cys)SNVLikely pathogenicrs587783601GRCh37Chr X, 48382363: 48382363
14EBPNM_006579.2(EBP): c.214T> C (p.Cys72Arg)SNVLikely pathogenicrs587783602GRCh37Chr X, 48382373: 48382373
15EBPNM_006579.2(EBP): c.218G> A (p.Gly73Glu)SNVLikely pathogenicrs587783603GRCh37Chr X, 48382377: 48382377
16EBPNM_006579.2(EBP): c.292_296delTCTCA (p.Ser98Thrfs)deletionPathogenicrs587783604GRCh37Chr X, 48382451: 48382455
17EBPNM_006579.2(EBP): c.299T> C (p.Leu100Pro)SNVLikely pathogenicrs587783605GRCh37Chr X, 48382458: 48382458
18EBPNM_006579.2(EBP): c.301+2T> ASNVPathogenicrs587783606GRCh37Chr X, 48382462: 48382462
19EBPNM_006579.2(EBP): c.303G> T (p.Trp101Cys)SNVLikely pathogenicrs587783607GRCh38Chr X, 48526990: 48526990
20EBPNM_006579.2(EBP): c.304A> T (p.Lys102Ter)SNVPathogenicrs587783608GRCh38Chr X, 48526991: 48526991
21EBPNM_006579.2(EBP): c.310T> C (p.Tyr104His)SNVPathogenicrs587783609GRCh38Chr X, 48526997: 48526997
22EBPNM_006579.2(EBP): c.311A> G (p.Tyr104Cys)SNVLikely pathogenicrs587783610GRCh38Chr X, 48526998: 48526998
23EBPNM_006579.2(EBP): c.314C> A (p.Ala105Asp)SNVLikely pathogenicrs587783611GRCh37Chr X, 48385389: 48385389
24EBPNM_006579.2(EBP): c.320G> A (p.Gly107Glu)SNVLikely pathogenicrs587783612GRCh37Chr X, 48385395: 48385395
25EBPNM_006579.2(EBP): c.328C> T (p.Arg110Ter)SNVPathogenicrs587783613GRCh37Chr X, 48385403: 48385403
26EBPNM_006579.2(EBP): c.331T> C (p.Tyr111His)SNVLikely pathogenicrs587783614GRCh37Chr X, 48385406: 48385406
27EBPNM_006579.2(EBP): c.464_465delCT (p.Ser155Cysfs)deletionPathogenicrs587783615GRCh37Chr X, 48385668: 48385669
28EBPNM_006579.2(EBP): c.480T> G (p.Tyr160Ter)SNVPathogenicrs587783616GRCh37Chr X, 48386632: 48386632
29EBPNM_006579.2(EBP): c.481G> A (p.Gly161Arg)SNVLikely pathogenicrs587783617GRCh37Chr X, 48386633: 48386633
30EBPNM_006579.2(EBP): c.511C> T (p.Arg171Cys)SNVLikely pathogenicrs141925556GRCh37Chr X, 48386663: 48386663
31EBPNM_006579.2(EBP): c.527A> G (p.His176Arg)SNVLikely pathogenicrs587783618GRCh37Chr X, 48386679: 48386679
32EBPNM_006579.2(EBP): c.632T> G (p.Leu211Arg)SNVLikely pathogenicrs587783619GRCh37Chr X, 48386784: 48386784
33EBPNM_006579.2(EBP): c.201_203dupCTG (p.Cys67_Trp68insCys)duplicationLikely pathogenicrs797045542GRCh37Chr X, 48382360: 48382362
34EBPNM_006579.2(EBP): c.225dupT (p.His76Serfs)duplicationPathogenicrs797045543GRCh37Chr X, 48382384: 48382384
35EBPNM_006579.2(EBP): c.329_332dupGATA (p.Tyr111Terfs)duplicationPathogenicrs797045544GRCh37Chr X, 48385404: 48385407
36EBPNM_006579.2(EBP): c.369_379delCATCACAGCTTinsAG (p.Ile124_Cys127delinsGly)indelLikely pathogenicrs797045545GRCh38Chr X, 48527185: 48527195
37EBPNM_006579.2(EBP): c.423_427delCCGCCinsT (p.Arg142Serfs)indelPathogenicrs797045546GRCh38Chr X, 48527239: 48527243
38EBPNM_006579.2(EBP): c.484dupG (p.Asp162Glyfs)duplicationPathogenicrs797045547GRCh38Chr X, 48528248: 48528248

Expression for genes affiliated with Chondrodysplasia Punctata, X-Linked Dominant

About this section
Search GEO for disease gene expression data for Chondrodysplasia Punctata, X-Linked Dominant.

Pathways for genes affiliated with Chondrodysplasia Punctata, X-Linked Dominant

About this section

GO Terms for genes affiliated with Chondrodysplasia Punctata, X-Linked Dominant

About this section

Cellular components related to Chondrodysplasia Punctata, X-Linked Dominant according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1nuclear envelopeGO:00056359.8EBP, STS
2endoplasmic reticulumGO:00057838.8EBP, NSDHL, STS
3intracellular membrane-bounded organelleGO:00432318.7EBP, NSDHL, STS
4endoplasmic reticulum membraneGO:00057898.5EBP, NSDHL, STS

Biological processes related to Chondrodysplasia Punctata, X-Linked Dominant according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cholesterol biosynthetic processGO:00066959.3EBP, NSDHL
2cholesterol metabolic processGO:00082039.0EBP, NSDHL

Sources for Chondrodysplasia Punctata, X-Linked Dominant

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet